Publication | Closed Access

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor

ObesityMetabolic SyndromeNutritionBariatric SurgeryMedicineMulticentre StudyGastroenterologyOne-year TreatmentObesity ManagementGastrointestinal Lipase InhibitorPharmacologyObesity Prevention